Detalles de la búsqueda
1.
Current Approaches for Predicting Human PK for Small Molecule Development Candidates: Findings from the IQ Human PK Prediction Working Group Survey.
AAPS J
; 24(5): 85, 2022 07 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35854202
2.
Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor XIa Inhibitors: Demonstrating the Power of an Integrated S1 Protease Family Approach.
J Med Chem
; 63(15): 8088-8113, 2020 08 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32551603
3.
Modulation of Oral Bioavailability and Metabolism for Closely Related Cyclic Hexapeptides.
Int J Pept Res Ther
; 24(1): 35-48, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29527142
4.
Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors.
J Med Chem
; 58(16): 6348-58, 2015 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-26181851
5.
Discovery of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinase.
J Med Chem
; 54(20): 7066-83, 2011 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-21936542
Resultados
1 -
5
de 5
1
Próxima >
>>